Tulane University has taken a significant step in downtown New Orleans by signing a purchase-and-sale agreement to acquire the long-vacant Charity Hospital. The university is shifting from prospective tenant to owner and lead developer in a project approximately valued at $500 million. This redevelopment will focus on transforming over 650,000 square feet of the building into spaces for research, labs, and classrooms.
On June 23, 2026, it was reported that Tulane entered into the agreement with 1532 Tulane Holdco, LLC. The process marks Tulane’s transition to an ownership and lead-developer role, moving beyond its initial plans as a tenant. The pre-construction phase is set to commence in the coming weeks, with financial closing anticipated by fall 2026.
Located at 1532 Tulane Ave in the BioDistrict, Charity Hospital spans about 1,000,000 square feet. Tulane will occupy a significant portion, as they pivot the focus of the space to education and innovation initiatives. The development is supported by the Goldring Family Foundation, along with BioDistrict New Orleans and city and state partners.
This project represents a major shift in private-sector real estate dynamics in New Orleans. Tulane’s involvement as the lead developer increases the probability of project completion and positively impacts the risk profile for potential lenders and investors. The undertaking is expected to reshape the leasing market in the BioDistrict by introducing a blend of lab, office, academic, housing, and retail spaces.
Looking ahead, the financial closing is expected by fall 2026, with groundbreaking slated soon after. The project’s completion is targeted for 2029. The redevelopment promises substantial economic impact and job creation, impacting construction contractors and local businesses throughout its execution.